Impact Factor
3.75
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.98
1,149 total citations
h5-index
37
h5 depth signal
Cited share
75.7%
234 of 309
Total citations
1,149
Citation footprint
Metric signal
4.10
External metric anchor
Self-citation
7.8%
90 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
1,207
China
221
United States
57
South Korea
37
United Kingdom
17
Citing Fields of Research
Cardiology
778
Lipids
467
Vascular Disorders
361
Diabetes
333
Endocrinology & Metabolism
179
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,998
Articles tracked across the journal lifetime
Indexed publication set
309
234 cited publications
Last 12 months
166
16.6 publications/month
Open access share
94.6%
157 OA publications in the last year
Leading citing country
Japan
1,207 citing publications
Leading citing field
Cardiology
778 citing publications
Latest tracked publication
1 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1994-
v1n1, 1994-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Lipids
Vascular Disorders
Diabetes
Endocrinology & Metabolism
Issuing & Sponsoring Bodies
Contributor
Nihon Dōmyaku Kōka Gakkai
Broad Categories
Vascular Diseases
Lipids
Cardiology
Vascular Disorders
Urology
MeSH Descriptors
Arteriosclerosis
Thrombosis
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.5551/jat.rv22057
Open DOI
Diet and Atherosclerosis Prevention: Rethinking the Significance of “The Japan Diet”
Although the mortality rate from cardiovascular disease (CVD) in Japan remains lower than that in Western countries, the need for the prevention of atherosclerotic diseases still merits emphasis. Cardiovascular disease develops due to th...
02
DOI 10.5551/jat.rv22056
Open DOI
The PREVENT Risk Equations and Cardiovascular Prevention in East Asia
Cardiovascular disease remains a leading cause of morbidity and mortality in East Asia, although its epidemiological profile differs substantially from that of Western populations. As East Asia experiences rapid increases in chronic kidn...
03
DOI 10.5551/jat.errv22051
Open DOI
A Literature Review on the Waist Circumference Criteria for Metabolic Syndrome in Japan: Evidence and Implications for Cardiovascular Risk Stratification
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
04
DOI 10.5551/jat.ed312
Open DOI
Major Bleeding During Factor Xa Inhibitor Therapy: Lessons from the Pre-Andexanet Era in Japan
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
05
DOI 10.5551/jat.66069
Open DOI
Clinical Efficacy with Evolocumab among Japanese Patients in PROFICIO: A Pooled Analysis of 1,040 Patients
Aims: Lowering low-density lipoprotein cholesterol (LDL-C) is essential for reducing the risk of atherosclerotic cardiovascular disease (ASCVD). This study assessed the clinical efficacy of evolocumab, a human monoclonal antibody targeti...
06
DOI 10.5551/jat.66089
Open DOI
Role of T1-weighted MRI in Identifying Coronary Intraplaque Hemorrhage: CATCH the Truly High-Risk Plaque
Intraplaque hemorrhage (IPH) is a key feature of plaque vulnerability that contributes to atherothrombotic events. Non-invasive coronary plaque imaging has been challenging because of the small size of the coronary arteries and motion ca...
07
DOI 10.5551/jat.66030
Open DOI
Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study
Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent worldwide. Conventional fibrates effectively lower triglycerides but may elevate liver enzymes and creatinine, limiting long-term use. Pemafibrate...
08
DOI 10.5551/jat.ed302
Open DOI
An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
09
DOI 10.5551/jat.65959
Open DOI
Comparison of Clinical Characterization and Therapeutic Strategies between Homozygous Familial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
Aims: Homozygous Familial hypercholesterolemia (HoFH) is a rare genetic disease characterized by very high levels of low-density lipoprotein cholesterol (LDL-C). Owing to LDL receptor activity being completely or nearly all lost in HoFH,...
10
DOI 10.5551/jat.66062
Open DOI
Impact of High-Intensity Statins and Low-Density Lipoprotein Cholesterol on the Outcomes of Coronary Intervention for Chronic Coronary Syndrome in Japan
Aim: The clinical effect of high-intensity statin therapy after percutaneous coronary intervention (PCI) in Japanese patients with chronic coronary syndrome (CCS) remains unclear. We investigated the association between high-intensity st...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 6, no. 6 (2009).
Supplement accompany some v.
Also issued online.
Official publication of the Japan Atherosclerosis Society.